Medicare Enrolled

Dr. Robert Aronson, M.D.

Pulmonary Disease · Olympia Fields, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
20303 CRAWFORD AVE STE 120, Olympia Fields, IL 60461
7089836060
In practice since 2006 (19 years)
NPI: 1598824039 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aronson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aronson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aronson

Dr. Robert Aronson is a pulmonary disease specialist in Olympia Fields, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aronson performed 228 Medicare services across 226 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aronson received a total of $4,177 from 30 pharmaceutical and/or device companies across 242 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aronson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 228 Medicare services $4,177 industry payments

Medicare Practice Summary

Medicare Utilization ↗
228
Medicare services
Bottom 16% in IL for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
226
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~12 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
102 $58 $150
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
102 $33 $75
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
12 $91 $720
New patient office visit, complex (60-74 min) 12 $126 $379
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,177
Total received (2018-2024)
Avg $597/year across 7 years
Top 33% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
242
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,177 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14
2023
$348
2022
$554
2021
$91
2020
$343
2019
$1,599
2018
$1,228

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$14
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$970
Boehringer Ingelheim Pharmaceuticals, Inc.
$469
Novartis Pharmaceuticals Corporation
$441
Grifols USA, LLC
$356
Sunovion Pharmaceuticals Inc.
$203
AstraZeneca Pharmaceuticals LP
$186
Mylan Specialty L.P.
$176
JAZZ PHARMACEUTICALS INC.
$169
Actelion Pharmaceuticals US, Inc.
$167
Philips Electronics North America Corporation
$144
Electromed, Inc.
$141
Genentech USA, Inc.
$138
Jazz Pharmaceuticals Inc.
$78
Regeneron Healthcare Solutions, Inc.
$69
Shire North American Group Inc
$64
Takeda Pharmaceuticals U.S.A., Inc.
$57
GENZYME CORPORATION
$41
Inogen, Inc.
$36
ADVANCED RESPIRATORY, INC
$35
Circassia Pharmaceuticals Inc
$34
Janssen Pharmaceuticals, Inc
$34
Vapotherm Inc
$31
Gilead Sciences, Inc.
$29
Avadel CNS Pharmaceuticals, LLC
$20
Axsome Therapeutics, Inc.
$19
Harmony Biosciences LLC
$18
Merck Sharp & Dohme LLC
$16
Insmed, Inc.
$13
Merck Sharp & Dohme Corporation
$12
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 45.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ANORO · Arikayce · BROVANA · DIFICID · DUPIXENT · Esbriet · FASENRA · GLASSIA · Horizant · INOGEN ONE G3 OXYGEN CONCENTRATOR · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · LONHALA MAGNAIR · LUMRYZ · NIOX VERO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Perforomist · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Olympia Fields?
Compare pulmonary diseases in the Olympia Fields area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
152
Per 100K population
2.9
County median income
$81,797
Nearest hospital
FRANCISCAN HEALTH OLYMPIA & CHICAGO HEIGHTS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Aronson is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Aronson experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Aronson performed 102 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aronson receive payments from pharmaceutical companies?
Yes. Dr. Aronson received a total of $4,177 from 30 companies across 242 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aronson's costs compare to other pulmonary diseases in Olympia Fields?
Dr. Aronson's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aronson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →